{
    "doc_id": "v1_data/DeepSeek-V3_gpqa-diamond_responses_125.json",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "An organic chemist performs two reactions.\nReaction I:\n(S)-5-methoxyhexan-3-one is treated with LAH followed by an acidic workup.\nReaction II:\nPentane-2,4-dione is treated with excess NaBH4 followed by an acidic workup.\nThe progress of the reactions is monitored using TLC. After the reactions are 100% completed, the products from both reactions are combined, and run on both a normal-phase HPLC column and an HPLC column packed with the chiral stationary phase.\nHow many peaks does the chemist observe in the chromatograms?\nA. 4 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC\nB. 3 peaks in both chiral HPLC and normal-phase HPLC\nC. 3 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC\nD. 5 Peaks in chiral HPLC and 4 peaks in normal-phase HPLC",
        "response": "To determine the number of peaks observed in the chromatograms, let's analyze the products of each reaction and their separation in normal-phase and chiral HPLC.\n\n---\n\n### **Reaction I:**\n**(S)-5-methoxyhexan-3-one** is treated with LAH (LiAlH\u2084), a strong reducing agent, followed by acidic workup.  \n- LAH reduces the ketone to an alcohol.  \n- The product is **(S)-5-methoxyhexan-3-ol**.  \n- This is a single chiral compound.\n\n---\n\n### **Reaction II:**\n**Pentane-2,4-dione** is treated with excess NaBH\u2084, a milder reducing agent, followed by acidic workup.  \n- NaBH\u2084 reduces both ketone groups to alcohols.  \n- The product is **pentane-2,4-diol**.  \n- This compound has two stereocenters, leading to **three stereoisomers**:  \n  1. (2R,4R)-pentane-2,4-diol  \n  2. (2S,4S)-pentane-2,4-diol  \n  3. (2R,4S)-pentane-2,4-diol (meso compound, optically inactive)\n\n---\n\n### **Combined Products:**\nThe products from both reactions are combined:  \n1. **(S)-5-methoxyhexan-3-ol** (1 chiral compound)  \n2. **Pentane-2,4-diol** (3 stereoisomers)  \n\nTotal: **4 compounds**.\n\n---\n\n### **Chromatograms:**\n\n1. **Normal-phase HPLC:**  \n   - Separates compounds based on polarity.  \n   - **(S)-5-methoxyhexan-3-ol** and **pentane-2,4-diol** have different polarities, so they will separate into **2 peaks**.\n\n2. **Chiral HPLC:**  \n   - Separates enantiomers and diastereomers based on chirality.  \n   - **(S)-5-methoxyhexan-3-ol** is a single chiral compound (1 peak).  \n   - **Pentane-2,4-diol** has three stereoisomers (3 peaks).  \n   - Total: **4 peaks**.\n\n---\n\n### **Answer:**  \n**A. 4 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC**"
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 43,
            "label": "context",
            "text": "An organic chemist performs two reactions.\n",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 43,
            "end": 130,
            "label": "context",
            "text": "Reaction I:\n(S)-5-methoxyhexan-3-one is treated with LAH followed by an acidic workup.\n",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 130,
            "end": 220,
            "label": "context",
            "text": "Reaction II:\nPentane-2,4-dione is treated with excess NaBH4 followed by an acidic workup.\n",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 220,
            "end": 274,
            "label": "context",
            "text": "The progress of the reactions is monitored using TLC. ",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 274,
            "end": 464,
            "label": "context",
            "text": "After the reactions are 100% completed, the products from both reactions are combined, and run on both a normal-phase HPLC column and an HPLC column packed with the chiral stationary phase.\n",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 464,
            "end": 526,
            "label": "context",
            "text": "How many peaks does the chemist observe in the chromatograms?\n",
            "source": "question"
        },
        {
            "id": "ctx6",
            "annotation": false,
            "start": 526,
            "end": 529,
            "label": "context",
            "text": "A. ",
            "source": "question"
        },
        {
            "id": "ctx7",
            "annotation": false,
            "start": 529,
            "end": 588,
            "label": "context",
            "text": "4 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC\nB. ",
            "source": "question"
        },
        {
            "id": "ctx8",
            "annotation": false,
            "start": 588,
            "end": 755,
            "label": "context",
            "text": "3 peaks in both chiral HPLC and normal-phase HPLC\nC. 3 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC\nD. 5 Peaks in chiral HPLC and 4 peaks in normal-phase HPLC",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 163,
            "label": "planning",
            "text": "To determine the number of peaks observed in the chromatograms, let's analyze the products of each reaction and their separation in normal-phase and chiral HPLC.\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 163,
            "end": 168,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 168,
            "end": 188,
            "label": "restatement",
            "text": "### **Reaction I:**\n",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 188,
            "end": 301,
            "label": "fact",
            "text": "**(S)-5-methoxyhexan-3-one** is treated with LAH (LiAlH\u2084), a strong reducing agent, followed by acidic workup.  \n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 301,
            "end": 343,
            "label": "fact",
            "text": "- LAH reduces the ketone to an alcohol.  \n",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 343,
            "end": 391,
            "label": "reasoning",
            "text": "- The product is **(S)-5-methoxyhexan-3-ol**.  \n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 391,
            "end": 428,
            "label": "reasoning",
            "text": "- This is a single chiral compound.\n\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 428,
            "end": 433,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 433,
            "end": 454,
            "label": "restatement",
            "text": "### **Reaction II:**\n",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 454,
            "end": 560,
            "label": "fact",
            "text": "**Pentane-2,4-dione** is treated with excess NaBH\u2084, a milder reducing agent, followed by acidic workup.  \n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 560,
            "end": 610,
            "label": "fact",
            "text": "- NaBH\u2084 reduces both ketone groups to alcohols.  \n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 610,
            "end": 651,
            "label": "reasoning",
            "text": "- The product is **pentane-2,4-diol**.  \n",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 651,
            "end": 728,
            "label": "reasoning",
            "text": "- This compound has two stereocenters, leading to **three stereoisomers**:  \n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 728,
            "end": 760,
            "label": "example",
            "text": "  1. (2R,4R)-pentane-2,4-diol  \n",
            "source": "response"
        },
        {
            "id": "resp14",
            "annotation": false,
            "start": 760,
            "end": 792,
            "label": "example",
            "text": "  2. (2S,4S)-pentane-2,4-diol  \n",
            "source": "response"
        },
        {
            "id": "resp15",
            "annotation": false,
            "start": 792,
            "end": 859,
            "label": "example",
            "text": "  3. (2R,4S)-pentane-2,4-diol (meso compound, optically inactive)\n\n",
            "source": "response"
        },
        {
            "id": "resp16",
            "annotation": false,
            "start": 859,
            "end": 864,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp17",
            "annotation": false,
            "start": 864,
            "end": 891,
            "label": "restatement",
            "text": "### **Combined Products:**\n",
            "source": "response"
        },
        {
            "id": "resp18",
            "annotation": false,
            "start": 891,
            "end": 940,
            "label": "planning",
            "text": "The products from both reactions are combined:  \n",
            "source": "response"
        },
        {
            "id": "resp19",
            "annotation": false,
            "start": 940,
            "end": 993,
            "label": "fact",
            "text": "1. **(S)-5-methoxyhexan-3-ol** (1 chiral compound)  \n",
            "source": "response"
        },
        {
            "id": "resp20",
            "annotation": false,
            "start": 993,
            "end": 1038,
            "label": "fact",
            "text": "2. **Pentane-2,4-diol** (3 stereoisomers)  \n\n",
            "source": "response"
        },
        {
            "id": "resp21",
            "annotation": false,
            "start": 1038,
            "end": 1063,
            "label": "reasoning",
            "text": "Total: **4 compounds**.\n\n",
            "source": "response"
        },
        {
            "id": "resp22",
            "annotation": false,
            "start": 1063,
            "end": 1068,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp23",
            "annotation": false,
            "start": 1068,
            "end": 1092,
            "label": "restatement",
            "text": "### **Chromatograms:**\n\n",
            "source": "response"
        },
        {
            "id": "resp24",
            "annotation": false,
            "start": 1092,
            "end": 1120,
            "label": "restatement",
            "text": "1. **Normal-phase HPLC:**  \n",
            "source": "response"
        },
        {
            "id": "resp25",
            "annotation": false,
            "start": 1120,
            "end": 1166,
            "label": "fact",
            "text": "   - Separates compounds based on polarity.  \n",
            "source": "response"
        },
        {
            "id": "resp26",
            "annotation": false,
            "start": 1166,
            "end": 1292,
            "label": "reasoning",
            "text": "   - **(S)-5-methoxyhexan-3-ol** and **pentane-2,4-diol** have different polarities, so they will separate into **2 peaks**.\n\n",
            "source": "response"
        },
        {
            "id": "resp27",
            "annotation": false,
            "start": 1292,
            "end": 1314,
            "label": "restatement",
            "text": "2. **Chiral HPLC:**  \n",
            "source": "response"
        },
        {
            "id": "resp28",
            "annotation": false,
            "start": 1314,
            "end": 1381,
            "label": "fact",
            "text": "   - Separates enantiomers and diastereomers based on chirality.  \n",
            "source": "response"
        },
        {
            "id": "resp29",
            "annotation": false,
            "start": 1381,
            "end": 1454,
            "label": "reasoning",
            "text": "   - **(S)-5-methoxyhexan-3-ol** is a single chiral compound (1 peak).  \n",
            "source": "response"
        },
        {
            "id": "resp30",
            "annotation": false,
            "start": 1454,
            "end": 1517,
            "label": "reasoning",
            "text": "   - **Pentane-2,4-diol** has three stereoisomers (3 peaks).  \n",
            "source": "response"
        },
        {
            "id": "resp31",
            "annotation": false,
            "start": 1517,
            "end": 1543,
            "label": "reasoning",
            "text": "   - Total: **4 peaks**.\n\n",
            "source": "response"
        },
        {
            "id": "resp32",
            "annotation": false,
            "start": 1543,
            "end": 1548,
            "label": "restatement",
            "text": "---\n\n",
            "source": "response"
        },
        {
            "id": "resp33",
            "annotation": false,
            "start": 1548,
            "end": 1566,
            "label": "restatement",
            "text": "### **Answer:**  \n",
            "source": "response"
        },
        {
            "id": "resp34",
            "annotation": false,
            "start": 1566,
            "end": 1628,
            "label": "conclusion",
            "text": "**A. 4 Peaks in chiral HPLC and 2 peaks in normal-phase HPLC**",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx4",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e1",
            "from_node_id": "ctx5",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e2",
            "from_node_id": "resp0",
            "to_node_id": "resp2",
            "label": "reason:plan-step"
        },
        {
            "id": "e3",
            "from_node_id": "resp0",
            "to_node_id": "resp3",
            "label": "reason:plan-step"
        },
        {
            "id": "e4",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:fact-detail"
        },
        {
            "id": "e5",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:fact-detail"
        },
        {
            "id": "e6",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e7",
            "from_node_id": "resp5",
            "to_node_id": "resp6",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e8",
            "from_node_id": "resp1",
            "to_node_id": "resp7",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e9",
            "from_node_id": "resp1",
            "to_node_id": "resp8",
            "label": "reason:plan-step"
        },
        {
            "id": "e10",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e11",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:fact-detail"
        },
        {
            "id": "e12",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:fact-detail"
        },
        {
            "id": "e13",
            "from_node_id": "resp10",
            "to_node_id": "resp11",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e14",
            "from_node_id": "resp9",
            "to_node_id": "resp12",
            "label": "reason:fact-detail"
        },
        {
            "id": "e15",
            "from_node_id": "resp10",
            "to_node_id": "resp12",
            "label": "reason:fact-detail"
        },
        {
            "id": "e16",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e17",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:concept-example"
        },
        {
            "id": "e18",
            "from_node_id": "resp12",
            "to_node_id": "resp14",
            "label": "reason:concept-example"
        },
        {
            "id": "e19",
            "from_node_id": "resp12",
            "to_node_id": "resp15",
            "label": "reason:concept-example"
        },
        {
            "id": "e20",
            "from_node_id": "resp15",
            "to_node_id": "resp16",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e21",
            "from_node_id": "resp16",
            "to_node_id": "resp17",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e22",
            "from_node_id": "resp17",
            "to_node_id": "resp18",
            "label": "plan:plan-nextplan"
        },
        {
            "id": "e23",
            "from_node_id": "resp6",
            "to_node_id": "resp19",
            "label": "reason:fact-detail"
        },
        {
            "id": "e24",
            "from_node_id": "resp18",
            "to_node_id": "resp19",
            "label": "reason:plan-step"
        },
        {
            "id": "e25",
            "from_node_id": "resp19",
            "to_node_id": "resp20",
            "label": "reason:fact-detail"
        },
        {
            "id": "e26",
            "from_node_id": "resp19",
            "to_node_id": "resp21",
            "label": "reason:fact-detail"
        },
        {
            "id": "e27",
            "from_node_id": "resp20",
            "to_node_id": "resp21",
            "label": "reason:fact-detail"
        },
        {
            "id": "e28",
            "from_node_id": "resp21",
            "to_node_id": "resp22",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e29",
            "from_node_id": "resp22",
            "to_node_id": "resp23",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e30",
            "from_node_id": "resp23",
            "to_node_id": "resp24",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e31",
            "from_node_id": "resp18",
            "to_node_id": "resp25",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e32",
            "from_node_id": "resp24",
            "to_node_id": "resp25",
            "label": "reason:fact-detail"
        },
        {
            "id": "e33",
            "from_node_id": "resp19",
            "to_node_id": "resp26",
            "label": "reason:fact-detail"
        },
        {
            "id": "e34",
            "from_node_id": "resp20",
            "to_node_id": "resp26",
            "label": "reason:fact-detail"
        },
        {
            "id": "e35",
            "from_node_id": "resp21",
            "to_node_id": "resp26",
            "label": "reason:fact-detail"
        },
        {
            "id": "e36",
            "from_node_id": "resp25",
            "to_node_id": "resp26",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e37",
            "from_node_id": "resp23",
            "to_node_id": "resp27",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e38",
            "from_node_id": "resp27",
            "to_node_id": "resp28",
            "label": "reason:fact-detail"
        },
        {
            "id": "e39",
            "from_node_id": "resp6",
            "to_node_id": "resp29",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e40",
            "from_node_id": "resp28",
            "to_node_id": "resp29",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e41",
            "from_node_id": "resp12",
            "to_node_id": "resp30",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e42",
            "from_node_id": "resp15",
            "to_node_id": "resp30",
            "label": "reason:plan-step"
        },
        {
            "id": "e43",
            "from_node_id": "resp21",
            "to_node_id": "resp31",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e44",
            "from_node_id": "resp29",
            "to_node_id": "resp31",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e45",
            "from_node_id": "resp30",
            "to_node_id": "resp31",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e46",
            "from_node_id": "resp31",
            "to_node_id": "resp32",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e47",
            "from_node_id": "resp32",
            "to_node_id": "resp33",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e48",
            "from_node_id": "resp31",
            "to_node_id": "resp34",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e49",
            "from_node_id": "resp33",
            "to_node_id": "resp34",
            "label": "reason:plan-step"
        }
    ]
}